(141 days)
Not Found
No
The description focuses on signal processing, programmable thresholds for auto-triggering, and transmission of data for professional analysis, without mentioning AI or ML.
No
The device is an Arrhythmia ECG Event Recorder designed for self-testing and analysis of ECG recordings, not for providing therapy. It monitors and transmits data for diagnosis, rather than treating a condition.
Yes
The device is described as an "Arrhythmia ECG Event Recorder" designed for "self-testing by patients at home and for analysis by medical professionals at a remote Monitoring Center." It records and transmits ECG signals for the purpose of "detecting" events based on "specific rhythms and arrhythmias." This process of detecting and analyzing medical conditions (cardiac arrhythmia) from physiological data (ECG signals) directly qualifies it as a diagnostic device.
No
The device description explicitly states it comprises a chestworn ECG sensor and a handheld device, both of which are hardware components. It is not solely software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The CG-6108 system is an Arrhythmia ECG Event Recorder. It directly measures electrical activity of the heart (ECG) from the patient's chest. This is an in vivo measurement, meaning it's taken from within the living body, not from a sample outside the body.
- Intended Use: The intended use is to record and transmit ECG signals to help identify cardiac arrhythmias. This is a diagnostic process, but it's based on physiological signals, not analysis of biological samples.
Therefore, the device falls under the category of a medical device that performs physiological monitoring, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The CG-6108 system is an Arrhythmia ECG Event Recorder designed for self-testing by patients at home and for analysis by medical professionals at a remote Monitoring Center. It comprises a chestworn ECG sensor and a handheld device with a proprietary application, configured to process and transmit the ECG recordings.
The CG-6108 Arrhythmia ECG Event Recorder is intended for use by patients who experience transient symptoms that may suggest cardiac arrhythmia.
Product codes (comma separated list FDA assigned to the subject device)
DXH
Device Description
The CG-6108 system is an Arrhythmia ECG Event Recorder designed for self-testing by patients at home and for analysis by medical professionals at a remote Monitoring Center. It comprises a chestworn ECG sensor and a handheld device with a proprietary application, configured to process and transmit the ECG recordings.
The chest-worn unit includes 3 electrodes on a harness and it houses a battery, an ASIC and a Bluetooth transceiver for the acquisition, recording, and transmission of the ECG signal. The ECG signals are transmitted via Bluetooth to the handheld device. When an event is detected it is wirelessly transmitted to the CG Monitoring Center for professional analysis. The handheld device is equipped with shared memory used to record the signal received from the sensor and to allow preand post processing options through the use of this memory in a dual memory loop configuration, both running in parallel. One loop is auto-triggered, with programmable thresholds, that starts recording based on specific rhythms and arrhythmias detected or manually activated by the patient. The second, and longer, recording loop is controlled remotely to provide the physician with more information, when requested by the CG Monitoring Center.
The handheld device automatically transmits the recorded ECG, via cellular link, to the Monitoring Center. When cellular service is unavailable the patient can transmit via landline telephone.
The PMP4 Medical Application is designed for wireless mobile platforms, e.g. PDA, SmartPhone and for static platforms, i.e., PC. It is used to receive from the CG-6108 (and other Card Guard's devices), the test results and other medical data, to process and save these test results, and synchronize data and test results with the PMP4 Medical Center. The Application is a part of a personal medical system solution. The PMP4 Medical Application performs the following activities:
- Receives medical test inputs from the external accessories 1.
- Collects medical test data and other related information as defined for each test 2.
- Accesses historical test and related data stored on the device 3.
- Transmits medical test data and additional information to Center for professional evaluation/backup 4.
- נ. Receives data from Center
- Enables configuring GPRS data connection (based on mobile phone GPRS/CDMA 6. capabilities), changing user name and password.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
ECG
Anatomical Site
Chest
Indicated Patient Age Range
Not Found
Intended User / Care Setting
self-testing by patients at home and for analysis by medical professionals at a remote Monitoring Center.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2920 Telephone electrocardiograph transmitter and receiver.
(a)
Identification. A telephone electrocardiograph transmitter and receiver is a device used to condition an electrocardiograph signal so that it can be transmitted via a telephone line to another location. This device also includes a receiver that reconditions the received signal into its original format so that it can be displayed. The device includes devices used to transmit and receive pacemaker signals.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for Card Guard Scientific Survival LTD. The words "CARD GUARD" are in bold, and the words "Scientific Survival LTD" are in a smaller font size below the words "CARD GUARD". To the right of the words is a line graph that resembles an EKG.
.4
CG-6108 Arrhythmia ECG Event Recorder 510(k) Summary of Safety and Effectiveness
12
| 1. General K060911 pg1/2 | |
|---|---|
| Submitter | Card Guard Scientific Survival Ltd., |
| Address | 2 Pekeris St. P.O.B. 527 Rehovot 76100, Israel |
| Contact: | Alex Gonorovsky, RA Manager |
| Phone: | 972-8-9484019 Fax: 972-8-9484044 |
| E-mail: | galex@cardguard.com |
| Device | |
| Trade Name: | CG-6108 Arrhythmia ECG Event Recorder |
| Classification: | Transmitters and receivers, electrocardiograph, telephone |
| Product Code: | DXH |
| Regulation No: | 21 CFR 870.2920 |
| Class: | II |
Definition and Intended Use 2.
The CG-6108 system is an Arrhythmia ECG Event Recorder designed for self-testing by patients at home and for analysis by medical professionals at a remote Monitoring Center. It comprises a chestworn ECG sensor and a handheld device with a proprietary application, configured to process and transmit the ECG recordings.
The chest-worn unit includes 3 electrodes on a harness and it houses a battery, an ASIC and a Bluetooth transceiver for the acquisition, recording, and transmission of the ECG signal. The ECG signals are transmitted via Bluetooth to the handheld device. When an event is detected it is wirelessly transmitted to the CG Monitoring Center for professional analysis. The handheld device is equipped with shared memory used to record the signal received from the sensor and to allow preand post processing options through the use of this memory in a dual memory loop configuration, both running in parallel. One loop is auto-triggered, with programmable thresholds, that starts recording based on specific rhythms and arrhythmias detected or manually activated by the patient. The second, and longer, recording loop is controlled remotely to provide the physician with more information, when requested by the CG Monitoring Center.
The handheld device automatically transmits the recorded ECG, via cellular link, to the Monitoring Center. When cellular service is unavailable the patient can transmit via landline telephone.
PMP4 Medical Application 3.
The PMP4 Medical Application is designed for wireless mobile platforms, e.g. PDA, SmartPhone and for static platforms, i.e., PC. It is used to receive from the CG-6108 (and other Card Guard's devices), the test results and other medical data, to process and save these test results, and synchronize data and test results with the PMP4 Medical Center. The Application is a part of a personal medical system solution. The PMP4 Medical Application performs the following activities:
- Receives medical test inputs from the external accessories 1.
- Collects medical test data and other related information as defined for each test 2.
- Accesses historical test and related data stored on the device 3.
- Transmits medical test data and additional information to Center for professional evaluation/backup 4.
- న. Receives data from Center
- Enables configuring GPRS data connection (based on mobile phone GPRS/CDMA 6. capabilities), changing user name and password.
1
921
4. Referenced Standards
No performance standards have been developed under Section 514 of the Federal Food, Drug and Cosmetic Art for wireless ECG event recording devices. The CG-6108 meets the requirements of the following standards:
- (1) MDD 93/42/EEC Medical Device Directive Council Directive 93/42/EEC; June 14, 1993
- EN 475: Medical devices Electrically-generated alarm signals ; April 1995 (2)
- EN 980: Graphical symbols for use in the labeling of medical devices; August 2003 (3)
- (4) EN 1041: Terminology, Symbols and Information provided with Medical Devices; Information supplied by the manufacturer with medical devices; April 1998
- EN ISO 9001 : Quality management systems Requirements; December 2000 (ર)
- EN ISO 13485: Quality systems Medical devices; August 2000 (6)
- EN ISO 14971: Medical devices application of risk management to medical devices; March 2001 (7)
- EN ISO 10993 Biological evaluation of medical devices Part 1: Evaluation and testing; Dec. 1997 (8)
- EN 60601-1: Medical electrical equipment; Part 1: General requirements for safety; Sept. 2002 (9)
- (10) EN 60601-1-2: Medical electrical equipment; Part 1: 2. Collateral Std: EMC; requirements and tests; 2001
- (11) EN 60601-1-4: Medical electrical equipment; Part 1: 4. Collateral Std: Programmable electric medical systems; Apr. 01
5. Indications for use
The CG-6108 Arrhythmia ECG Event Recorder is intended for use by patients who experience transient symptoms that may suggest cardiac arrhythmia.
6. Principles of operation
The CG-6108 Arrhythmia ECG Event Recorder comprises a chest-worn ECG sensor with three electrodes and a handheld device with a proprietary PMP4 Medical Application, used to process and transmit the ECG recordings. The battery powered chest-worn unit has an ASIC and a fransceiver for the acquisition, recording, and transmission of the ECG signals are transmitted via Bluetooth to the handheld device equipped with the PMP4 Medical Application, which incorporates an algorithm specially developed for detection of arrhythmia artifacts, e.o., &F. A detected artifact triggers transmission of the signal to the CG Monitoring Center for analysis.
7. Substantial Equivalence
The clearance for the CG-6108 is sought on the grounds of its claimed substantial equivalence (SE) to the following predicate devices:
- Card Guard's CG-6106 K963811 for its memory loop monitoring principle of operation and 1. the identity of the intended use.
- Card Guard's CG-6550 K003220 Personal 3-lead ECG Transmitter for its arrhythmia artifacts 2. detection algorithm (e.g. AF)
- Card Guard's PMP4 SelfCheck ECG K042254 for the BT transmission capability and for 3. interfacing and including the PMP4 Medical Application - the CG proprietary SW for storing, measuring, displaying and transmitting data gathered from medical sensors.
8. Conclusions
The CG-6108 Arrhythmia ECG Event Recorder constitutes a safe and reliable means for designed for self-testing by patients who experience transient symptoms that may suggest cardiac arrhythmia. Its material composition and operation present no adverse health effect or safety risks when used as intended.
The device is as safe, as effective and performs as well as or better than its cleared predicate device.
2
Image /page/2/Picture/2 description: The image shows the seal for the Department of Health and Human Services. The seal is circular and contains the words "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" around the top half of the circle. In the center of the seal is an abstract image of an eagle.
JUN 1 8 2007
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Card Guard Scientific Survival Ltd. c/o Mr. Alex Gonorovsky Manager, Regulatory Affairs 2 Pekeris St. P.O. Box 527 Rehovot 76101 ISRAEL
Re: K060911
Trade Name: CG-6108 Arrhythmia ECG Event Recorder Regulation Number: 21 CFR 870.2920 Regulation Name: Telephone Electrocardiograph Transmitters and Receivers Regulatory Class: Class II (two) Product Code: DXH Dated: August 4, 2006 Received: August 4, 2006
Dear Mr. Gonorovsky:
This letter corrects our substantially equivalent letter of August 22, 2006 and the subsequent correction letter of March 27, 2007.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can
3
Page 2 - Mr. Alex Gonorovsky
be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
B. Bimmerman for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
ﻨﻴﻮ 510(k) Number (if known): Кобо9 II
Device Name: CG-6108 Arrhythmia ECG Event Recorder
Indications for Use:
Intended for use by patients who experience transient symptoms that may suggest cardiac arrhythmia
Prescription Use 区 (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
の 2007年 10月 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 10時 1
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
B.himma
(Division Sign-Off) Division of Cardiovascular Devices 510(k) Number_K /1/20911
Page I of I
(Posted November 13, 2003)